A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.
Farlow M; Anand R; Messina J Jr; Hartman R; Veach J; European Neurology, 2000, vol. 44, issue 4, p 236, ISSN 00143022. ISBN 00143022.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef